Jones Financial Companies Lllp Lyra Therapeutics, Inc. Call Options Transaction History
Jones Financial Companies Lllp
- $298 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LYRA
# of Institutions
56Shares Held
25MCall Options Held
56.6KPut Options Held
33.9K-
Perceptive Advisors LLC New York, NY12.8MShares$1.15 Million0.07% of portfolio
-
Black Rock Inc. New York, NY2.83MShares$254,6980.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.77MShares$158,9020.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA1.39MShares$125,1110.08% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.06MShares$95,2330.02% of portfolio
About Lyra Therapeutics, Inc.
- Ticker LYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,826,400
- Market Cap $2.86M
- Description
- Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...